patientMpower

Revolutionising patient-centred healthcare, reducing outpatient visits and hospitalisation by up to 80%

Rebecca Borton, Health Outcomes & Project Lead

The patientMpower platform is a configurable, multi-pathway remote, clinical-grade monitoring solution to empower patient-centred care at home.

The patient facing solution enables home assessments of lung function, oxygen saturation, blood pressure, temperature, weight, PROMS, symptoms, medication use and step count. The clinician facing portal provides real time patient data, with streamlined clinical processes, patient tailored alerting, EMR integration and inbuilt spirometry quality validation.

With SBRI Healthcare funding, a randomised, prospective study of the health outcomes and health economic impact of digitally-enabled hybrid versus clinic care is ongoing, focused on lung transplant at one of the five lung transplant centres in the UK.

With lung transplant, patients require close monitoring with hospital check-ups every 3-4 months. This places a burden on patients, clinicians and services. patientMpower enables a “right-time, right place” approach to patients following lung transplant addressing the challenge of monitoring and management.

Case studies have shown use of the platform reduced clinic visits after lung transplant by up to 66%, whilst enabling rapid identification of potential complications. Across other clinical areas, use of patientMpower has shown:

An 80% reduction in readmissions for heart failure (2)
A 70% reduction in clinic visits for renal transplant (3)
A 65% reduction in length of stay for cystic fibrosis (4)
60% of patients achieved clinically meaningful symptom improvement for COPD (5)
A 91% adherence to home monitoring in interstitial lung disease (6)

2. https://www.gov.ie/en/publication/25977-improved-access-to-care-for-heart-failure-patients-in-midlands-regional-hospital-portlaoise/
3. http://www.beaumont.ie/media/NKTSV1.26_Annual_Report_20221.pdf
4. https://patientmpower.com/virtual-care-for-cystic-fibrosis-experience-from-galway-university-hospital/
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100740/
   pdf/11845_2021_Article_2633.pdf
6. https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-024-02787-1

• patientMpower currently supports patient-centred care for more than 13,000 patients for 12 condition types across 35 centres in 10 countries including Ireland, North America, the UK and across the EU
• In November 2023, the 1 millionth spirometry manoeuvre was recorded using the patientMpower platform
• UKCA and CE marked, ORCHA certified, ISO 13485 certified, ISO 27001 certified
• New partnership with Erasmus MC European Centre for Excellence for Interstitial Lung Disease (ILD) and Sarcoidosis to use patientMpower as the technology partner for digital care of the complex lung disease ILD
• Winner of the ‘Indigenous SME - Most Innovative Product’ category at the 2023 National HealthTech Innovation Awards

"We already had experience of using patientMpower’s solution with our patients for the last 2-3 years. Feedback has been really encouraging however we lacked scientific data to show how it benefits patients. This SBRI Healthcare supported study will hopefully provide this information in a healthcare setting, using a randomised controlled trial format."

Principal Investigator, Dr John Blaikley, Honorary Consultant in Lung Transplantation, Manchester University NHS Foundation Trust

"patientMpower's platform provides AI-enabled feedback of home spirometry quality to our patients and the healthcare team. Our analyses have shown that good quality spirometry standards can be achieved with this approach.

High quality data is important. Home monitoring can help us identify possible complications quickly, but it's the quality of the data that gives the team the confidence to make clinical decisions accordingly."

Dr Caroline Patterson, Consultant Physician, Respiratory & Transplantation, Royal Papworth Hospital, and Dr Karl Sylvester, Consultant Healthcare Scientist, Cambridge University Hospitals

December 2024